Finance

Lists
SLVNF:OTCMKTS
Solvonis Therapeutics PLC
0,0020 $
0,00%
(0,00) 1D
28 там., 10:51:42 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLVNF...
Mkt. cap
9,08 млн
Avg. vol.
59,58 мың
Volume
0,00
52-wk high
0,01 $
52-wk low
0,00 $
Shares outstanding
7,90 млрд
No. of employees
6
Mkt. cap
9,08 млн
Avg. vol.
59,58 мың
Volume
0,00
52-wk high
0,01 $
52-wk low
0,00 $
Shares outstanding
7,90 млрд
No. of employees
6
About Solvonis Therapeutics PLC
CEO-
Employees6
Founded2017
Headquarters-
Sector-
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
2025 ж. нау.
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
808,50 м.
808,50 м.
699,50 м.
699,50 м.
Operating expense
808,50 м.
808,50 м.
979,00 м.
979,00 м.
Total operating expenses
808,50 м.
808,50 м.
979,00 м.
979,00 м.
Operating income
-808,50 м.
-808,50 м.
-979,00 м.
-979,00 м.
Other non operating income
-
-
-
-
EBT including unusual items
-810,50 м.
-810,50 м.
-2,06 млн
-2,06 млн
EBT excluding unusual items
-810,50 м.
-810,50 м.
-928,00 м.
-928,00 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-810,50 м.
-810,50 м.
-2,06 млн
-2,06 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
2,00 мың
2,00 мың
Interest expense
-2,00 мың
-2,00 мың
-
-
Net interest expenses
-2,00 мың
-2,00 мың
2,00 мың
2,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары